Douglas P Dyer Selected Research

Chemokine CXCL11

1/2022

Chemokine redundancy versus specificity in the context of CXCR3 and its ligands.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas P Dyer Research Topics

Disease

6	Inflammation (Inflammations) 01/2022 - 02/2014
2	Neoplasms (Cancer) 01/2022 - 01/2017
1	Infections 01/2022
1	Thrombocytopenia (Thrombopenia) 12/2021

Drug/Important Bio-Agent (IBA)

2	ChemokinesIBA 01/2019 - 01/2017
1	Chemokine CXCL11IBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Platelet Factor 4IBA 12/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	AnticoagulantsIBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	CytokinesIBA 03/2014
1	Hyaluronic Acid (Hyaluronan)IBA 02/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	Carrier Proteins (Binding Protein)IBA 02/2014

Therapy/Procedure

1	Radiotherapy 01/2022
1	Therapeutics 01/2022
1	Transplantation 03/2014